MediQuest Announces Sale of Late Stage Onychomycosis Program to EFFELL…

MediQuest Therapeutics announces the sale of late stage Onychomycosis/Onycholysis programs to EFFELL LLC, the first in a series of asset sales.

(PRWeb September 19, 2012)

Read the full story at

Comments are closed.

Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog